Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tino Dyhring

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Combinatorial Chemistry & High Throughput Screening|May 4, 2011
A fluorescence polarization based screening assay for identification of small molecule inhibitors of the PICK1 PDZ domainThor S Thorsen, Kenneth L Madsen, Tino Dyhring, et al.
Journal of Medicinal Chemistry|May 26, 2006
New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modelingKarine Audouze, Elsebet Østergaard Nielsen, Gunnar M Olsen, et al.
Brain Research|October 26, 2013
Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cellsAndreas H Rasmussen, Dorte Strøbæk, Tino Dyhring, et al.
The Journal of Biological Chemistry|August 6, 2005
Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonistsPouya Movahed, Bo A G Jönsson, Bryndis Birnir, et al.
The Journal of Biological Chemistry|December 12, 2012
Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptorsKasper Harpsøe, Helle Hald, Daniel B Timmermann, et al.
Biochemical Pharmacology|December 31, 2019
Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptorsMarloes van Hout, Jessica Klein, Philip K Ahring, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Journal of Medicinal Chemistry|October 13, 2007
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonistsJianguo Ji, Michael R Schrimpf, Kevin B Sippy, et al.
Biochemical Pharmacology|September 15, 2007
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal modelsJianguo Ji, William H Bunnelle, David J Anderson, et al.
Biochemical Pharmacology|December 31, 2019
Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptorsKarin Sandager-Nielsen, Philip K Ahring, Jessica Klein, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Combinatorial Chemistry & High Throughput Screening|May 4, 2011
A fluorescence polarization based screening assay for identification of small molecule inhibitors of the PICK1 PDZ domainThor S Thorsen, Kenneth L Madsen, Tino Dyhring, et al.
Journal of Medicinal Chemistry|May 26, 2006
New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modelingKarine Audouze, Elsebet Østergaard Nielsen, Gunnar M Olsen, et al.
Brain Research|October 26, 2013
Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cellsAndreas H Rasmussen, Dorte Strøbæk, Tino Dyhring, et al.
The Journal of Biological Chemistry|August 6, 2005
Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonistsPouya Movahed, Bo A G Jönsson, Bryndis Birnir, et al.
The Journal of Biological Chemistry|December 12, 2012
Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptorsKasper Harpsøe, Helle Hald, Daniel B Timmermann, et al.
Biochemical Pharmacology|December 31, 2019
Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptorsMarloes van Hout, Jessica Klein, Philip K Ahring, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Journal of Medicinal Chemistry|October 13, 2007
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonistsJianguo Ji, Michael R Schrimpf, Kevin B Sippy, et al.
Biochemical Pharmacology|September 15, 2007
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal modelsJianguo Ji, William H Bunnelle, David J Anderson, et al.
Biochemical Pharmacology|December 31, 2019
Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptorsKarin Sandager-Nielsen, Philip K Ahring, Jessica Klein, et al.
Pageof 3